A detailed history of Private Capital Group, LLC transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 1,632 shares of AUPH stock, worth $14,606. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,632
Previous 1,632 -0.0%
Holding current value
$14,606
Previous $20,000 20.0%
% of portfolio
0.01%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 21, 2022

SELL
$10.05 - $22.48 $2,050 - $4,585
-204 Reduced 11.11%
1,632 $20,000
Q4 2021

Jan 24, 2022

SELL
$17.78 - $33.08 $4,196 - $7,806
-236 Reduced 11.39%
1,836 $42,000
Q3 2021

Oct 13, 2021

BUY
$10.93 - $23.55 $6,350 - $13,682
581 Added 38.97%
2,072 $46,000
Q2 2021

Jul 26, 2021

SELL
$10.0 - $14.52 $11,400 - $16,552
-1,140 Reduced 43.33%
1,491 $19,000
Q1 2021

Apr 12, 2021

BUY
$12.3 - $18.73 $32,361 - $49,278
2,631 New
2,631 $34,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.27B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.